SUMO1 单克隆抗体 (VB7) | SUMO1 mono

【产品形式】：艾美捷为您提供的SUMO1 单克隆抗体 (VB7)经过WB, IP等实验验证。推荐使用稀释比率分别为：WB 1:1000-10000, IP 1:200。

【背景资料】：SUMOylation of substrate proteins takes place in a manner analogous to that of the ubiquitin conjugation system, utilising E1, E2 and E3 enzymes in an ATP dependent process and often requires a short sequence containing the consensus Ψ-K-X-D/E (where lysine is the modified amino acid, Ψ is a large hydrophobic residue and X is any amino acid residue) on the substrate protein for protein SUMO modification to occur. Whilst the specific roles of the three SUMO isoforms have not been fully elucidated they have been shown to regulate distinct mitotic processes in mammalian cells. In addition SUMO2 and SUMO3 can form homogenous and mixed chains, with SUMO1, which does not contain the internal SUMO consensus sites (K11) found in SUMO2 and SUMO3, thought to terminate mixed polySUMO chains.

英国Viva Bioscience公司是一家研发、生产并销售蛋白降解相关产品的公司。其产品主要用于细胞自噬、泛素化和蛋白酶体研究（也覆盖其他蛋白降解相关的产品），其产品价格合理、质量可靠且具有创新性。目前VIVA Bioscience提供逾460种产品，涉及细胞自噬、蛋白泛素化和讲解相关的所有试剂盒、蛋白、底物以及多种抑制剂、激活剂等全系列产品。作为多家进口品牌的中国区域总代理，艾美捷科技与Viva Bioscience一道为中国科研工作者们提供更好、更新的自噬、泛素化和蛋白酶体等研究工具。

点击SUMO1 单克隆抗体 (VB7)查看更详细产品说明，更多应用、储存、价格、货期等信息请致电400-6800-868垂询Viva Bioscience中国区域授权总代理艾美捷科技有限公司。